Clinical trials
Cardiomyopathy, Dilated trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2011 | 5 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Unknown status | 3 |
| Active, not recruiting | 2 |
| Recruiting | 2 |
| Suspended | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| French Cardiology Society | 3 |
| Institut National de la Santé Et de la Recherche Médicale, France | 3 |
| University Hospital, Bordeaux | 3 |
| Assistance Publique Hopitaux De Marseille | 2 |
| Nantes University Hospital | 2 |
| University Hospital, Montpellier | 2 |
| Ancora Heart, Inc. | 1 |
| Bristol-Myers Squibb | 1 |
| Karim WAHBI | 1 |
| Universitaire Ziekenhuizen KU Leuven | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiomyopathy, Dilated | 21 |
| Heart Failure | 8 |
| Cardiomyopathies | 3 |
| Cardiomyopathy, Hypertrophic | 3 |
| Coronary Disease | 3 |
| Brugada Syndrome | 2 |
| Cardiomyopathy, Restrictive | 2 |
| Long QT Syndrome | 2 |
| Polymorphic Catecholaminergic Ventricular Tachycardia | 2 |
| Arrhythmias, Cardiac | 1 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.